News & Updates
Filter by Specialty:
SG’s migrant workers fall for COVID-19-related misinformation
In Singapore, language and cultural barriers hinder migrant workers from accessing timely and accurate official information regarding the coronavirus disease 2019 (COVID-19) pandemic, according to a new study.
SG’s migrant workers fall for COVID-19-related misinformation
29 Oct 2021
Post-ICH antiplatelet therapy not linked to recurrent ICH
Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.
Post-ICH antiplatelet therapy not linked to recurrent ICH
28 Oct 2021
Exposure to indoor cleaning products during pregnancy ups child’s risk of asthma
Exposure to indoor cleaning products before or around conception and pregnancy seems to worsen the risk of childhood asthma in the offspring, a recent study has found.
Exposure to indoor cleaning products during pregnancy ups child’s risk of asthma
28 Oct 2021
ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis
Interleukin-17 inhibition with the biologic disease-modifying antirheumatic drug (DMARD) secukinumab appears to produce a substantial reduction in synovitis in psoriatic arthritis, in addition to improvements in the signs and symptoms of the disease, according to the results of the phase III ULTIMATE.
ULTIMATE: Biologic DMARD affords inflammation control in psoriatic arthritis
28 Oct 2021
Modified dual therapy on par with recommended regimen in H. pylori infection
A modified dual therapy as first-line treatment for H. pylori infection demonstrates equal efficacy and compliance relative to recommended regimens, reveals a study. Moreover, a generally modified dual therapy has fewer side effects.
Modified dual therapy on par with recommended regimen in H. pylori infection
28 Oct 2021
Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
Dietary intake of alpha linolenic acid (ALA) appears to reduce the risk of mortality from all causes, cardiovascular disease (CVD), and coronary heart disease (CHD) but may slightly increase the risk of cancer mortality, according to a systematic review and meta-analysis. Moreover, an association exists between higher blood levels of ALA and a lower risk of all-cause and CHD mortality.